(Q37146052)

18 August 2017

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation (English)

1 reference

stem cell transplantation

18 August 2017

1 reference

1 reference

inferred from title

myelodysplastic syndrome

1 reference

1 reference

acute myeloid leukemia

1 reference

10

Per Ljungman

1 reference

18 August 2017

11

Alois Gratwohl

1 reference

18 August 2017

6

Dietger Niederwieser

1 reference

18 August 2017

1

Nicolaus Kröger

1 reference

18 August 2017

3

Anja van Biezen

1 reference

18 August 2017

15

Argiris Symeonidis

1 reference

18 August 2017

13

Dietrich Beelen

1 reference

18 August 2017

4

Axel Zander

1 reference

18 August 2017

8

Tapani Ruutu

1 reference

18 August 2017

Ronald Brand

2

1 reference

18 August 2017

Judith Dierlamm

5

1 reference

18 August 2017

Agnès Devergie

7

1 reference

18 August 2017

Jackie Cornish

9

1 reference

18 August 2017

Catherine Cordonnier

12

1 reference

18 August 2017

Eric Deconinck

14

1 reference

18 August 2017

Theo de Witte

16

1 reference

18 August 2017

Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT)

17

1 reference

18 August 2017

10 March 2009

1 reference

18 August 2017

1 reference

18 August 2017

94

1 reference

18 August 2017

4

1 reference

18 August 2017

542-549

1 reference

Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematol

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Treatment of therapy-related leukemia and myelodysplastic syndrome.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients—Report of the French Society of Bone Marrow Transplantation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663618

Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors

4 December 2018

1 reference

12 December 2020

Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia

1 reference

12 December 2020

Secondary leukemias induced by topoisomerase-targeted drugs

1 reference

12 December 2020

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

1 reference

12 December 2020

1 reference

12 December 2020

Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

12 December 2020

Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy

1 reference

12 December 2020

1 reference

12 December 2020

Prognosis in therapy-related acute myeloid leukemia and impact of karyotype

1 reference

12 December 2020

13-cis retinoic acid treatment for myelodysplastic syndromes

1 reference

12 December 2020

Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia

1 reference

12 December 2020

10.3324/HAEMATOL.2008.000927

Identifiers

DOI

1 reference

release_oqxflvb6gjdenluovcrs3hgwm4

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oqxflvb6gjdenluovcrs3hgwm4

24 November 2022

mapped directly with Wikidata item

1 reference

18 August 2017

1 reference